The Latest Breaking News from Pfizer

Pfizer Inc (NYSE:PFE) voluntarily recalls Accuretic (quinapril HCl/hydrochlorothiazide) and two authorized generic versions due to the presence of nitrosamine, N-nitroso-quinapril, above an acceptable level.  Pfizer will recall six lots of Accuretic tablets, one lot of quinapril and hydrochlorothiazide tablets, and four lots of quinapril HCl/ hydrochlorothiazide tablets. Nitrosamines are common in water and…

Meanwhile the FDA dawdles over second boosters as new COVID-19 wave approaches

The Ministry of Public Health is aiming to administer a third booster shot to 70% of the country's elderly population ahead of the Thai New Year holiday next month, as they face a greater risk of infection and death from the coronavirus.

How effective would a second booster be? Who is eligible now? Why are third dose numbers lagging? Experts explain

LOS ANGELES — Coronavirus cases are on the upswing worldwide, prompting some officials to warn that California could see increases this spring because of the omicron subvariant BA.2 even though cases so far have been modest.

Until there’s a universal coronavirus vaccine, the future of additional shots is a murky work in progress—but more rounds seem increasingly likely.

The NHS said its Covid-19 vaccination programme will contact people when it is their turn to be vaccinated

Advocates point to the pandemic as proof of its value in healthcare even as critics dismiss its use in drug discovery as ‘hype’

Waiving Covid vaccine patents would help poor countries fight the disease. Pharma giants won't let that happen